The 1st patient advocacy track at EBMT: making a difference for patients
Anita Waldmann • 24 Mar 2019
The importance of the European Medicines Agency in CAR-T development
Ulrich Jäger • 17 Feb 2019
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.